These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 19012353)
1. Improving understanding of adjuvant therapy options by using simpler risk graphics. Zikmund-Fisher BJ; Fagerlin A; Ubel PA Cancer; 2008 Dec; 113(12):3382-90. PubMed ID: 19012353 [TBL] [Abstract][Full Text] [Related]
2. A demonstration of ''less can be more'' in risk graphics. Zikmund-Fisher BJ; Fagerlin A; Ubel PA Med Decis Making; 2010; 30(6):661-71. PubMed ID: 20375419 [TBL] [Abstract][Full Text] [Related]
3. The benefits of discussing adjuvant therapies one at a time instead of all at once. Zikmund-Fisher BJ; Angott AM; Ubel PA Breast Cancer Res Treat; 2011 Aug; 129(1):79-87. PubMed ID: 20945090 [TBL] [Abstract][Full Text] [Related]
4. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. Whelan T; Sawka C; Levine M; Gafni A; Reyno L; Willan A; Julian J; Dent S; Abu-Zahra H; Chouinard E; Tozer R; Pritchard K; Bodendorfer I J Natl Cancer Inst; 2003 Apr; 95(8):581-7. PubMed ID: 12697850 [TBL] [Abstract][Full Text] [Related]
5. A decision aid to assist in adjuvant therapy choices for breast cancer. Siminoff LA; Gordon NH; Silverman P; Budd T; Ravdin PM Psychooncology; 2006 Nov; 15(11):1001-13. PubMed ID: 16511899 [TBL] [Abstract][Full Text] [Related]
6. Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy. Feldman-Stewart D; Madarnas Y; Mates M; Tong C; Grunfeld E; Verma S; Carolan H; Brundage M Breast; 2013 Oct; 22(5):919-25. PubMed ID: 23721853 [TBL] [Abstract][Full Text] [Related]
7. Communicating risk information: the influence of graphical display format on quantitative information perception-Accuracy, comprehension and preferences. Price M; Cameron R; Butow P Patient Educ Couns; 2007 Dec; 69(1-3):121-8. PubMed ID: 17905553 [TBL] [Abstract][Full Text] [Related]
8. What eye-tracking methods can reveal about the role of information format in decision-aid processing: an exploratory study. Poirier MW; Decker C; Spertus JA; McDowd JM Patient Educ Couns; 2019 Nov; 102(11):1977-1984. PubMed ID: 31176556 [TBL] [Abstract][Full Text] [Related]
9. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB; Louis TA; Markman M; Mayer R; Roter D J Natl Cancer Inst; 2001 Jul; 93(13):979-89. PubMed ID: 11438563 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for breast cancer. NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506 [TBL] [Abstract][Full Text] [Related]
11. Presenting decision-relevant numerical information to Dutch women aged 50-70 with varying levels of health literacy: Case example of adjuvant systemic therapy for breast cancer. van Strien-Knippenberg IS; Timmermans DRM; Engelhardt EG; Konings IRHM; Damman OC PLoS One; 2024; 19(9):e0309668. PubMed ID: 39226280 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524 [TBL] [Abstract][Full Text] [Related]
13. A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ. Lo AC; Olson R; Feldman-Stewart D; Truong PT; Aquino-Parsons C; Bottorff JL; Carolan H Am J Clin Oncol; 2017 Dec; 40(6):574-581. PubMed ID: 25730602 [TBL] [Abstract][Full Text] [Related]
14. A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer. Hamelinck VC; Bastiaannet E; Pieterse AH; de Glas NA; Portielje JE; Merkus JW; den Hoed ID; van de Velde CJ; Liefers GJ; Stiggelbout AM Clin Breast Cancer; 2016 Oct; 16(5):379-388. PubMed ID: 27212474 [TBL] [Abstract][Full Text] [Related]
15. Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making. Engelhardt EG; Pieterse AH; van der Hout A; de Haes HJ; Kroep JR; Quarles van Ufford-Mannesse P; Portielje JE; Smets EM; Stiggelbout AM Eur J Cancer; 2016 Oct; 66():55-66. PubMed ID: 27525573 [TBL] [Abstract][Full Text] [Related]
16. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338 [TBL] [Abstract][Full Text] [Related]
17. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Lancet; 2005 May 14-20; 365(9472):1687-717. PubMed ID: 15894097 [TBL] [Abstract][Full Text] [Related]
18. Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study. Dalenc F; Penault-Llorca F; Cohen M; Houvenaeghel G; Piat JM; Liegeois P; Puyuelo L; Suchaud JP; Zouai M; Lacroix-Triki M; Radosevic-Robin N; Benkanoun C; Attar-Rabia H; Chauvet MP; Gligorov J; Belkacemi Y Clin Breast Cancer; 2017 Apr; 17(2):107-116. PubMed ID: 27856201 [TBL] [Abstract][Full Text] [Related]
19. A new graphical format to communicate treatment effects to patients-A web-based randomized controlled trial. Kasper J; van de Roemer A; Pöttgen J; Rahn A; Backhus I; Bay Y; Köpke S; Heesen C Health Expect; 2017 Aug; 20(4):797-804. PubMed ID: 27981688 [TBL] [Abstract][Full Text] [Related]